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stress and may be useful as oxidative stress and/orIntroductionThe erythrocyte is a very unique cell, not only because of its
biconcave shape, but also, because it is a cell without nuclei or other
organelles. Its main function is the transport/exchange of gases
through the human body. Inherent to its function in transporting
oxygen, a high content in hemoglobin (Hb) (95% of total protein in
erythrocyte) and, therefore in iron, turns the red blood cell (RBC) into
a preferential place for reactive oxygen species (ROS) formation.
Accumulation of ROS within the cell can lead to lipid peroxidation,
protein carbonylation and Hb denaturation, the reason why there is a
variety of antioxidant systems to counteract the effects of ROS,
namely, high quantities of enzymes, such as superoxide dismutase
(SOD), catalase and peroxidases, speciﬁcally glutathione peroxidase
(GSHPx) and peroxiredoxin 2 (Prx2). The latter is one of the most
abundant cytoplasmatic proteins of the erythrocytes [1–3], although
the way it operates in connection with other RBC antioxidant systemsculdade de Farmácia da Uni-
orto, Portugal. Fax: +351 222is still poorly clariﬁed; however, some recent studies indicate that
Prx2 plays a preponderant role in maintaining low endogenous levels
of hydrogen peroxide produced by Hb autoxidation [4,5].
Peroxiredoxins are a ubiquitous family of peroxidases with
antioxidant proprieties. There are 6 types of mammalian peroxiredo-
xins (I to VI), present in various tissues, and classiﬁed according to the
presence of a conserved amino acid sequence and catalysismechanism
[6,7]. Human erythrocyte Prx2 is a typical 2-cys peroxiredoxin, with a
thiol-dependent hydrogen peroxide scavenger activity regulated by
the thioredoxin (Trx)/Trx reductase/NADPH reducing system [7,8].
This protein has a molecular mass of 21.8 kDa [3,6] and exists in the
cytoplasm as dimers and decamers in dynamic equilibrium [6,9,10].
Although cellular location of Prx2 is considered to be cytosolic, it can
also be linked to the erythrocytemembrane [1,11–16]where it could be
involved in mechanisms of defense against lipid peroxidation [11,17].
We recently reported [15] the linkage of Prx2 to the membrane of
circulating RBCs in some Hereditary Spherocytosis (HS) patients;
moreover, this linkage was correlated with higher amounts of
membrane bound hemoglobin (MBH), a known marker of oxidative
stress. In fact, several studies have reported a rise in MBH, both in
physiologic (physical exercise [18], pregnancy [19,20]) and pathologic
(myocardial infarction [21], stroke [22], psoriasis [23]) oxidative stress
related conditions. Senescent RBCs, that present high values of MBH
[24], are smaller, denser and with a higher membrane rigidity. These
changes and the decreased enzyme activity in older RBCs, favor their
splenic removal; in fact, the hypoxic environment and the vascular
network that older RBCs have to face through spleen circulation, by
testing the RBC metabolic activity (to overwhelming oxidative stress)
and cell deformability, may condition their sequestration and removal.
The aim of the present workwas to determine if Prx2 linkage to the
RBCmembrane could be induced by oxidative stress conditions, and to
understand how this process occurs. We performed in vitro assays in
which catalase or both Hb autoxidation and catalase were inhibited,
under hydrogen peroxide (H2O2)-induced oxidative stress conditions.
Materials and methods
Preparation of erythrocyte suspension
Blood samples from healthy volunteers (n=3) were collected
using heparin as anticoagulant.
Plasma and buffy-coat were discarded and red blood cells were
washed in phosphate buffered saline (PBS) pH 7.4. The number of
cells/ml in the obtained erythrocyte suspensions was determined
using a hemocytometer, and, afterwards adjusted for 5×108 cell/ml
with PBS, pH 7.4.
In vitro assays
Erythrocyte suspensions (5×108 cell/ml; 10ml PBS, pH 7.4), under
the following different assay conditions, were incubated during
30 min at 37 °C, under gentle agitation:
RBCs under H2O2-induced oxidative stress
Erythrocytes were incubated with hydrogen peroxide 25 μM,
50 μM and 75 μM (the concentration of H2O2 stock solution was
measured according to Low et al. [5]). A control tube containing only
RBCs was used.
RBCs under H2O2-induced oxidative stress and catalase inhibition
Erythrocytes were incubated with 100 mM sodium azide (NaN3)
and H2O2 25 μM, 50 μM and 75 μM. A control tube containing only
RBCs and 100 mM NaN3 was used.
RBCs under H2O2-induced oxidative stress and inhibition of catalase and
Hb autoxidation
Before incubation, the erythrocytes were saturated with carbon
monoxide (CO) and carboxyhemoglobin formation was determined
by spectrophotometry [25]. Afterwards, RBCs were incubated with
NaN3 100 mM and H2O2 25 μM, 50 μM and 75 μM. A control tube
containing only RBCs saturated with CO and 100 mM NaN3 was used.
After incubation (for all in vitro assays), we removed an aliquot of
each RBC suspension, in order to evaluate the oxidative status of
cytosolic Prx2. Those erythrocyte aliquots were adjusted for 5×106
cell/ml with PBS, pH 7.4 (2 ml); to these RBC suspensions N-ethyl
maleimide (NEM) was added (ﬁnal concentration 100 mM) and,
afterwards, an incubation of 15 min at 37 °C, under gentle agitation,
was performed.
The remaining suspension was processed to obtain erythrocyte
membranes.
Preparation of erythrocyte membrane suspensions and hemolysates
To ensure minimal RBC membrane preparation variability, the
protocol was performed by the same individual during the course of
this study.
To prepare the erythrocyte membranes for electrophoretic analy-
sis, RBCs were washed in saline solution, after the 30 minuteincubation period. The RBCs were submitted to hypotonic lyses,
according to Dodge et al. [26]. The obtained membranes were washed
in Dodge buffer, adding in the ﬁrst two washes phenylmethylsulpho-
nyl ﬂuoride, as a protease inhibitor, at a ﬁnal concentration of 0.1 mM.
The hemolysates were obtained after the 15 minute incubation
period with NEM by hypotonic lyses with Dodge buffer of the pelleted
erythrocytes, previously washed with saline solution.
The protein concentration of the erythrocyte membrane suspen-
sions and of the hemolysates were determined by the Bradford's
method [27].
To prepare erythrocyte membranes for electrophoresis, the
membrane suspensions were treated with an equal volume of a
solubilization buffer (0.125M Tris HCl pH 6.8, 4% sodium dodecil
sulphate (SDS), 20% glycerol, 10% 2-mercaptoethanol) and heat
denatured, when working in reducing conditions.
In order to determine the redox form inwhich Prx2 was present in
the RBC cytosol, oxidizing conditions were utilized for the preparation
of the hemolysate suspensions (solubilization buffer without a
reducing agent) [5].
Immunoblot analysis for Prx2 in RBC membranes and hemolysates
Erythrocyte membrane suspensions and hemolysates were sub-
mitted to SDS-PAGE in a 12% acrylamide gel (30 μg protein/lane), using
the discontinuous Laemmli system [28]. An internal control of human
recombinant Prx2 protein (250 ng) (LabFrontier) was applied in all
electrophoresis. Proteins were electrophoretically transferred from
SDS gels to a nitrocellulose sheet with a porosity of 0.2 μm [29].
Additional reactive sites on the nitrocellulose were blocked by
incubation in low fat dry milk (5% w/v) and 0.1% Triton-X 100 in PBS
pH 7.0, for 1 h at room temperature and under gentle rotation. Prx2
immunoblotwas then carried out by incubating the nitrocellulosewith
monoclonal antibodies anti-human Prx2 (dilution 1:3000), produced
in mouse (LabFrontier), for 5 h; washing of the nitrocellulose was
followed by incubation with anti-mouse IgG peroxidase linked
(Sigma-Aldrich) for 1 h (dilution 1:3000). An enhanced chemilumi-
nescence method (SuperSignal West Pico Chemiluminescent Sub-
strate, Pierce) and a X-ray ﬁlm (Kodak) were used to develop the
immunoblot. The immunoblots were scanned (Darkroom CN UV/wl,
BioCaptMW version 99, Vilber Lourmat) and the amount of Prx2
linked to erythrocyte membrane was determined by densitometry
(Bio1D++version99, Vilber Lourmat, France) by comparisonwith the
internal control. The amount of Prx2 of each samplewas determined as
a ratio between the sample value and the internal control.
Membrane bound hemoglobin
The MBH was measured by spectrophotometry, after protein
dissociation with Triton-X 100 (5% w/v in Dodge buffer); the
absorbance was measured at 415 nm and this value was corrected
by the background absorbance at 700 nm; this value and protein
concentration were used to estimate MBH percentage [21].
Erythrocyte membrane lipoperoxidation
Erythrocyte membrane lipid peroxidation was determined using
the thiobarbituric acid (TBA) test according to Mihara and Uchiyama
[30]. The ratios of malonaldehyde/protein concentration (mg)
(MDA/prot) for each RBC membrane suspension were calculated to
obtain uniform data.
Spectral analysis of hemolysates
To analyze the Hb spectral outline, the absorption spectrum (400–
700 nm) was determined, by spectroscopy (plate reader PowerWave
XS, Bio Tek), in 1:50 dilutions of the hemolysates.
Results
To test our hypothesis that the linkage of Prx2 to the RBC
membrane could be induced by oxidative stress, and to better
understand how it occurs, we performed in vitro assays, exposing
erythrocyte suspensions to different oxidative conditions.
In Fig. 1, we present immunoblots for Prx2 of RBC membranes
prepared from the erythrocyte suspensions incubated without and
with increasing H2O2 concentrations (Fig. 1A), with the addition of a
catalase inhibitor (Fig. 1B) and in conditions that both catalase and
Hb autoxidation were inhibited (Fig. 1C). Using the same incubation
conditions and locking Prx2 redox forms present within the cell by
means of incubation with an oxidizing agent (NEM), the typical
immunoblots of Prx2 in the hemolysates are presented in Fig. 2.
When no H2O2 was added to the RBC suspension, we found that Prx2
was not linked to the RBC membrane for all tested conditions (Fig. 1)
and that Prx2 was present in the cytosol as monomers, the active
reduced form of Prx2 (Fig. 2); for growing peroxide concentrations,
Prx2 was detected in the RBC membrane in an increasing manner
when catalase was inhibited (Figs. 1B and C) and, when catalase was
active, Prx2 was not detected in the RBC membrane (Fig. 1A). By
analysis of the immunoblots of the hemolysates, we observed that
the monomeric form of Prx2 was present, as referred, in all
suspensions without H2O2 (Fig. 2) and in those where catalase was
not inhibited (Fig. 2A); in the presence of H2O2 and NaN3, the
dimeric oxidized form of Prx2 was detected in the cytosol (Fig. 2B
and C) and increasing amounts of Prx2 were linked to the RBC
membrane (Fig. 1B and C).
By using an internal control of human Prx2 in the immunoblots,
we evaluated the amount of Prx2 linked to the RBC membrane in
the different assay conditions (Fig. 3A). We also evaluated the MBH
in the several studied conditions (Fig. 3B). We found that without
H2O2, no Prx2 was detected in the RBC membrane and the value of
MBH was similar for all assay conditions. When H2O2 was added in
increasing concentrations to RBCs, in the suspensions with active
catalase, no Prx2 was linked to the membrane and the MBH
amounts were similar for all concentrations of H2O2 (Fig. 3A and B);
in the suspensions incubated with NaN3 and H2O2, both Prx2 and
MBH levels increased with H2O2 concentration. When catalase and
Hb autoxidation were inhibited, Prx2 membrane linkage increased
also with H2O2 concentration and, the amount of Prx2 linked to theFig. 1. Immunoblots for peroxiredoxin 2 (Prx2) of erythrocyte membranes prepared
from the RBC suspensions under the different assay conditions. All suspensions (5×108
cell/ml in PBS, pH 7.4) were incubated for 30 min at 37 °C under gentle agitation,
without and with increasing concentrations of H2O2 (25, 50 and 75 μM) (A); plus NaN3
(100 mM) to inhibit catalase (B) and, in order to inhibit both catalase and Hb
autoxidation, RBC suspensions previously saturated with CO were incubated with NaN3
(100 mM) (C). SDS-PAGE of erythrocyte hemolysates performed in a 12% acrylamide
gel, under reducing conditions. An internal control of human recombinant Prx2 was
always used. Molecular weight (MW) markers are presented on the right.
Fig. 2. Peroxiredoxin 2 (Prx2) immunoblots of hemolysates obtained after subjecting
erythrocytes to the different assay conditions. All RBC suspensions (5×108 cell/ml in
PBS, pH 7.4) were incubated for 30 min at 37 °C under gentle agitation, without and
with increasing concentrations of H2O2 (25, 50 and 75 μM) (A); plus NaN3 (100 mM) to
inhibit catalase (B) and, in order to inhibit both catalase and Hb autoxidation, RBC
suspensions saturated with CO were incubated with NaN3 (100 mM) (C). Afterwards,
aliquots of each suspension (5×106 cell/ml) were incubated (15 min at 37 °C under
gentle agitation) after addition of NEM (100 mM), in order to lock the Prx2 redox forms
present in the cytosol of the erythrocytes. SDS-PAGE of erythrocyte hemolysates
performed in a 12% acrylamide gel, under oxidizing conditions. An internal control of
human recombinant Prx2 was always used. Molecular weight (MW) markers are
presented on the right.membrane was higher than that observed when only catalase was
inhibited. The opposite was observed for MBH, though its values
presented also an increase with H2O2 concentration.
Regarding erythrocyte membrane lipoperoxidation, the levels of
MDA/prot increased with H2O2 concentration for all assay conditions
and in the RBC suspensions without active catalase this incrementwas
even higher, especially when associated with inhibition of Hb
autoxidation by CO (Table 1).
The Hb spectral analysis of the hemolysates, showed a rise in the
absorption peak characteristic of methemoglobin (metHb) (630 nm)
with increasing H2O2 concentration for the RBC suspensions
incubated with NaN3, and with both CO and NaN3; this peak was
Fig. 3. Erythrocyte membrane linked peroxiredoxin 2 (Prx2) (A) and membrane bound
hemoglobin (MBH) (B) amounts versus hydrogen peroxide concentration for the
different assay conditions applied to erythrocyte suspensions. Prx2 levels were
determined by densitometric analysis of the erythrocyte membrane immunoblots
(ratio between each Prx2 sample and the used internal control of human recombinant
Prx2); MBHwas determined by a spectroscopic method. Mean value and standard error
mean (n=3) are presented. (▪ RBCs— erythrocyte suspensions incubated without and
with H2O2; RBCs+NaN3 — erythrocyte suspensions incubated without and with
H2O2 and inhibition of catalase; □ RBCs+NaN3+CO — erythrocyte suspensions
incubated without and with H2O2 and inhibition of both catalase and Hb autoxidation).
Table 1
Lipid peroxidation of erythrocyte membranes (n=3) for the different incubation
conditions applied to erythrocyte suspensions, according to hydrogen peroxide
concentration.
MDA/prot (×10−2)
RBCs 2.3±0.5 2.2±1.0 3.3±1.7 5.0±2.1
RBCs+NaN3 3.4±0.3 5.3±0.7 5.6±0.8 6.5±1.7
RBCs+NaN3+CO 3.0±0.7 4.2±1.0 7.4±0.7 10.6±2.3
H2O2 (μM) 0 25 50 75
MDA — malonaldehyde; prot — protein concentration of erythrocyte membrane
suspensions (mg); Incubation conditions: RBCs— 5×108 cell/ml; RBCs+NaN3— 5×108
cell/ml+100 mM NaN3; RBCs+NaN3+CO — 5×108 cell/ml+100 mM NaN3+CO.
Data presented as mean±standard error mean (n=3).not observed in the hemolysates from the suspensions with active
catalase or from the suspensions incubated without H2O2 (data
not shown).
Discussion
In this work, we conﬁrmed the hypothesis we recently proposed
[15] that the linkage of Prx2 to the erythrocyte membrane in
circulating RBCs of Hereditary Spherocytosis patients could result
from the development of oxidative stress within the cell, since we
were able to cause the linkage of Prx2 to the membrane in vitro
through H2O2-mediated oxidative stress. Whether this linkage is a
simple result of oxidative stress damage to Prx2 or that it can serve a
beneﬁcial propose in vivo is still unknown.
In erythrocytes, Hb is particularly prone to go through an
autoxidation process by which superoxide anion, H2O2 and oxidized
Hb (metHb) are produced. In a normal mature erythrocyte the
antioxidant systems are able of detoxifying the cell of ROS and
oxidized hemoglobin is usually regenerated to the reduced functional
form by metHb reductases, one dependent on NADH and the other on
NADPH, as co-factors [31,32]. However, under oxidative stress
conditions, metHb formation increases and this Hb oxidized form
binds to the cytoplasmatic domain of the erythrocyte membrane band3 protein [33–36]. The rise of ROS within the cell also induces
membrane lipid peroxidation [37]. Both oxidative changesmay trigger
RBC membrane damage, such as decreased membrane transporter
activity, and changes in membrane permeability [38,39].
Although Prx2 is usually described as being localized in RBC
cytosol, performing its role in the antioxidant systems, our data
show that the linkage of Prx2 to the erythrocyte membrane may be
triggered under H2O2-induced oxidative stress conditions (Fig. 1).
Moreover, the binding of Prx2 to the membrane only occurred when
its dimeric oxidized form was present in the cytoplasm (Figs. 1 and
2). The active form of Prx2 is monomeric and the enzyme acquires
the dimeric (inactive) form when it is oxidized during the reaction
with H2O2 [7]. Low et al. [5] reported that in the presence of excess
H2O2, Prx2 becomes inactivated since it can only be regenerated to
monomers when H2O2 levels decrease, thus leading to an
accumulation of the dimeric form. In our study, when catalase
was active (incubations without NaN3), cytoplasmatic Prx2
remained in the monomeric active form (Fig. 2) and did not bind
to the RBC membrane (Figs. 1 and 3A), conﬁrming that catalase is
indeed responsible for scavenging high/exogenous quantities of
H2O2 [4,5,40]. This is strengthened by the results observed in the
other oxidative stress markers. Actually, MBH (Fig. 3B), lipoperox-
idation (Table 1) and Hb spectra in the hemolysates (data not
shown) were unaffected by H2O2 (for the tested concentrations),
maintaining basal values throughout increasing oxidative stress
conditions, suggesting that catalase and the other antioxidant
defenses effectively protected the erythrocyte suspensions from
exogenous H2O2 oxidative damage. These ﬁndings are in accordance
with the literature [4,41].
In a previous work [15], we hypothesized that Prx2 binding to the
membrane could be achieved through its linkage to oxidized Hb, as it
was reported elsewhere that Prx2 is able to bind to Hb [42]. In the
present work, we analyzed and compared the results obtained for the
erythrocyte suspensions where catalase or both catalase and Hb
autoxidation were inhibited. MBH showed to be a good marker of Hb
oxidation [18–24,43,44], as its rise was correlated with H2O2
concentration (Fig. 3B) and with the appearance of the absorption
peak characteristic of metHb (data not shown). However, it appears
that oxidized Hb and Prx2 membrane linkages are two separate
processes given that, when we were able to cause diminished Hb
linkage to the membrane (CO saturated suspensions, where Hb
autoxidation and, consequently, metHb formation where impaired),
higher amounts of Prx2 were found in the membrane, as compared to
those where Hb autoxidation was not inhibited. This ﬁnding probably
reﬂects the higher susceptibility of Prx2 to H2O2 in situations where
Hb is made unavailable to react with H2O2, rendering its effects upon
Prx2muchmore pronounced. Moreover, if Prx2 needed to be linked to
MBH in order to bind to the RBC membrane, we would not have found
more membrane linked Prx2 when less MBH was present, as was the
case.
Cha et al. [11] suggested that Prx2 membrane linkage could be a
mechanism used by the erythrocyte for its own protection against
the deleterious effects of MBH; furthermore, it has been described
that peroxiredoxins (Prx2 included) are capable of scavenging
peroxynitrite and organic peroxides, such as lipid hydroperoxides
[7,45–47]. As we used reducing conditions, we were not able to
determine in which form (monomer/dimer) Prx2 was linked to the
membrane; actually, further studies are needed to evaluate the
active/inactive state of Prx2 when it links to the membrane. In this
regard, our lipoperoxidation data show that erythrocyte membrane
lipid peroxidation rises with oxidative stress (Table 1), as has been
described elsewhere [48]. However, we cannot forget that, in the
studied conditions, Prx2 was inactive in the cytoplasm and, in the
membrane the depletion in NADPH would render a possible active
form also inactive. Therefore, MDA/prot values were increased and
surprisingly more so in those membranes with more Prx2, as we
increase H2O2 concentration. The difference between values of MDA/
prot in suspensions subjected to the same H2O2 concentration, when
referring to both erythrocyte suspensions with inactive catalase, may
possibly be explained by the fact that the presence of Prx2 could
contribute to enhance membrane structure destabilization (since
Prx2 is not a typical RBC membrane protein), rendering RBC
membranes more susceptible to lipid hydroperoxide attack. This
could explain why we found increased evidence of lipoperoxidation
in the membranes with highest amount of linked Prx2 (Table 1 and
Fig. 3A).
In conclusion, our data showed that the development of oxidative
stress within the erythrocyte triggers oxidation of Hb, which links to
the membrane, and is also responsible by the inactivation of Prx2 in
the cytosol, that is accompanied by its linkage to the membrane. Both
process seem to be independent and could be useful markers of
oxidative stress and/or of RBC damage/senescence. Moreover, in
accordance with the literature, catalase seems crucial in scavenging
high levels of H2O2, but there are other antioxidant systems, such as
Prx2, that seem to be more important in scavenging low H2O2 levels.
Further studies in oxidative stress related pathologies could be
valuable to better clarify the role of the linkage of Prx2 to the
erythrocyte membrane, since it can occur in circulating RBCs, namely,
in Hereditary Spherocytosis [15]. Nonetheless, we demonstrate for the
ﬁrst time that the linkage of cytosolic Prx2 to the erythrocyte
membrane can be induced by oxidative stress.
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